Fulyzaq Oral Tablet, Gastro-Resistant 125Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

FULYZAQ: Oral tablet, gastro-resistant (125mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_16303.JPG
Fulyzaq 125mg DR Tablet
Salix Pharmaceuticals, Inc
Pill Identification: 125SLXP 

What is this Medicine?

CROFELEMER (kroe FEL e mer) is used to treat diarrhea. It is helpful for treating diarrhea due to HIV-infection or AIDS.

CVS Pharmacy Patient Statistics for FULYZAQ: Oral tablet, gastro-resistant(125mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Fulyzaq 125mg Delayed-Release Tablet

NDC: 656490802
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Diarrhea

Storage Information
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Fulyzaq 125mg Delayed-Release Tablet
Drug Image file DrugItem_16303.JPG
Salix Pharmaceuticals, Inc
Pill Identification: 125SLXP 
Shape: oval
Color: white

Reported Side Effects for Fulyzaq 125mg Delayed-Release Tablet

Acne Incidence:
1.0-2.0%*
Severity: MILD
Onset: DELAYED
Increased Urination Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
1.0-2.0%*
Severity: MODERATE
Onset: DELAYED
Allergic Skin Reaction Incidence:
1.0-2.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
1.0-2.2%*
Severity: MODERATE
Onset: DELAYED
Depression Incidence:
1.0-2.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cell Counts Incidence:
1.0-2.0%*
Severity: MODERATE
Onset: DELAYED
High Bilirubin Level Incidence:
1.0-3.1%*
Severity: MODERATE
Onset: DELAYED
Kidney Stones Incidence:
1.0-2.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Sinus Infection Incidence:
1.0-2.0%*
Severity: MILD
Onset: DELAYED
Dry Mouth Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Muscle And/Or Bone Pain Incidence:
2.2%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
2.2%*
Severity: MILD
Onset: DELAYED
Hemorrhoids Incidence:
2.2%*
Severity: MODERATE
Onset: DELAYED
Nervousness Incidence:
2.2%*
Severity: MILD
Onset: DELAYED
Back Pain Incidence:
2.6%*
Severity: MILD
Onset: DELAYED
Joint Pain Incidence:
2.6%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
2.6%*
Severity: MILD
Onset: EARLY
Gas Incidence:
3.1%*
Severity: MILD
Onset: EARLY
Cough Incidence:
3.5%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
3.9-5.7%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with FULYZAQ

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5